Matysiak-Grzes Magdalena, Fischbach Jakub, Gut Paweł, Klimowicz Aleksandra, Gryczynska Maria, Wasko Ryszard, Ruchala Marek
Department of Endocrinology, Metabolism and Internal Diseases, University of Medical Sciences, Poznan, Poland.
Neuro Endocrinol Lett. 2013;34(2):97-101.
Malignant struma ovarii is a rare ovarian neoplasm composed predominantly of mature thyroid tissue.
A right ovarian tumor was discovered at ultrasound examination in a 20-year-old woman. Complete right ovariectomy was done - histopathological examination revealed papillary thyroid carcinoma arising in struma ovarii (malignant struma ovarii). Patient underwent subsequent total thyroidectomy - the thyroid was found to be without any pathological lesions. After operations the patient received ablative radioiodine treatment (200 mCi 131I). An 131I posttherapeutic whole-body radioiodine scintigraphy was performed and showed uptake in bone metastases. L-thyroxine TSH suppresive doses followed radioiodine ablation and thyroglobulin level is monitored. Next doses of radioiodine has been scheduled.
Authors suggest that the management of malignant struma ovarii should be the same as differentiated thyroid cancer, so after surgical excision of ovarian neoplasm, we recommend thyroidectomy, radiotherapy with 131I and levothyroxine suppressive therapy. Long-term follow-up for the detection of metastases or tumor recurrence by serial serum thyroglobulin measurements and 131I scan may be required in patients with this rare tumor.
恶性卵巢甲状腺肿是一种罕见的卵巢肿瘤,主要由成熟的甲状腺组织构成。
一名20岁女性在超声检查时发现右侧卵巢肿瘤。实施了右侧卵巢全切术——组织病理学检查显示卵巢甲状腺肿(恶性卵巢甲状腺肿)中出现乳头状甲状腺癌。患者随后接受了甲状腺全切术——发现甲状腺无任何病理病变。术后患者接受了消融性放射性碘治疗(200毫居里131I)。进行了一次131I治疗后全身放射性碘闪烁扫描,显示骨转移灶有摄取。放射性碘消融后给予左甲状腺素抑制剂量,并监测甲状腺球蛋白水平。已安排好下一次放射性碘剂量。
作者认为恶性卵巢甲状腺肿的治疗应与分化型甲状腺癌相同,因此在手术切除卵巢肿瘤后,我们建议进行甲状腺切除术、131I放疗和左甲状腺素抑制治疗。对于患有这种罕见肿瘤的患者,可能需要通过连续测定血清甲状腺球蛋白和131I扫描进行长期随访,以检测转移或肿瘤复发情况。